Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
03/2005
03/23/2005EP1515975A1 Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use
03/23/2005EP1515968A2 Quinuclidine derivatives and pharmaceutical compositions containing the same
03/23/2005EP1515960A1 2-thioxothiazole derivative, method for preparing the same, and pharmaceutical composition containing the same
03/23/2005EP1515959A1 Pharmaceutical salts of reboxetine
03/23/2005EP1515955A2 Chemical process
03/23/2005EP1515953A2 Novel hexahydro-pyridazine-3-carbocylic acid hydrazide or hydrazone derivatives, combinatorial libraries containing same, use thereof as medicines, pharmaceutical compositions containing same and methods for preparing same
03/23/2005EP1515952A2 Pyrazole-3-one derivative, method for preparing the same, and pharmaceutical composition containing the same
03/23/2005EP1515949A1 Mitotic kinesin inhibitors
03/23/2005EP1515947A1 Fluorinated cycloalkyl-derivatised benzoylguanidines and their use as a medicament
03/23/2005EP1515942A1 Carboxamides derivatives
03/23/2005EP1515941A1 2-naphthamide derivatives
03/23/2005EP1515753A1 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
03/23/2005EP1515743A2 Use of osteoprotegerin for the prevention and/or treatment of fibrosis/sclerosis
03/23/2005EP1515742A2 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof
03/23/2005EP1515736A1 Compositions against inflammatory processes
03/23/2005EP1515727A2 (halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents
03/23/2005EP1515718A2 Modulation of activation of glucocorticoid receptors by breakdown products of glucocorticoids
03/23/2005EP1515716A2 Indole derivatives having anti-angiogenetic activity
03/23/2005EP1515707A2 Method of treating atherosclerosis and other inflammatory diseases
03/23/2005EP1515698A2 Liposomes containing biologically active compounds
03/23/2005EP1515607A2 Antimicrobial compositions, products and methods employing same
03/23/2005EP1357937B1 Use of botuline toxin to obtain a product to be used in articular pathologies, particularly coxarthrosis, epicondylitis and rotator muscle cap pathology
03/23/2005EP1272218B1 A pharmaceutical composition for treatment of acute, chronic pain and/or neuropathic pain and migraines
03/23/2005EP1100516B1 Extracts of feverfew (tanacetum parthenium) against inflammatory disorders
03/23/2005CN1599745A Crystalline form of a ribofuranosyluronamide derivative; a human adenosine a2a receptor agonist
03/23/2005CN1599737A Ring fused pyrazole derivatives
03/23/2005CN1599730A Citric acid salt of a therapeutic compound and pharmaceutical compositions thereof
03/23/2005CN1599726A Pyrimidine compounds
03/23/2005CN1599721A CCR-3 receptor antagonists VII
03/23/2005CN1599717A Cyclic diamine compounds having fused-ring groups
03/23/2005CN1599613A Combinations for the treatment of immunoinflammatory disorders
03/23/2005CN1599610A Preparation of pharmaceutical salts of 4((z)-(4-bromophenyl)(ethoxyimino)methyl)-1'-((2, 4-dimethyl-1-oxido-3-pyridinyl)carbonyl)-4'-methyl-1, 4'bipiperidine as ccr5-antagonists for the treatment of aid
03/23/2005CN1599609A Combination of a selective PDE4 inhibitor and an adrenergic beta-2 receptor agonist
03/23/2005CN1599607A Carbinols for the treatment of neuropathic dysfunction
03/23/2005CN1599604A Use of 4-oxobutanoic acid derivatives in the treatment of inflammation
03/23/2005CN1599600A Pharmaceutical compositions for the oral administration of heparin or derivatives thereof
03/23/2005CN1597912A Preparation process of traditional Chinese medicine bone wine
03/23/2005CN1597677A Compounds and methods for modulation of estrogen receptors
03/23/2005CN1597667A Quinazoline derivatives as angiogenesis inhibitors
03/23/2005CN1596979A Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit
03/23/2005CN1596940A Traditional Chinese medicine for treating rheumatism
03/23/2005CN1596934A Head ache capsule preparation
03/23/2005CN1596931A Chinese medicinal composition for treating rheumatism rheumatoid disease and protrasion of lumbar intervertebral disk and its preparation method
03/23/2005CN1596930A Muscle and bone pain plaster and its making method
03/23/2005CN1596929A Plaster for treating acute and chronic muscle and bone disease and its preparation method
03/23/2005CN1596898A Biammonium glycyrrhizate powder-injection and its preparation method
03/23/2005CN1596895A Kusnezoff monkshood root methyl element microcapsule and its production method
03/23/2005CN1596889A Vitamin E emulsion and its freeze-dried emulsion compound and preparation method
03/23/2005CN1596888A Application of dihydromyricetrin
03/23/2005CN1193996C Inhibitor used as antioxygen and 5-lipoxygenase, and anti-inflammatory non-steroid carboxylic ester and amide of non-steroid anti-inflammatory agent
03/23/2005CN1193786C Preparation of Chinese herbal medicine for treating cold injury, various indurations and swelling, pain as well as its preparing method
03/23/2005CN1193785C Medicine for treating rheumatic and rheumatoid diseases
03/23/2005CN1193775C Medicine for treating atrophic arthritis, ankylosing sponylitis
03/23/2005CN1193764C Novel medicinal use and prepn process of steroid general saponin of Rhizomz Anemarrhenae as Chinese medicine
03/23/2005CN1193761C Controllable release system of glucocorticoid and its preparation method
03/23/2005CN1193743C Multilayer pharmaceutical product for release in the colon
03/22/2005US6870044 Regulatory sequences for use as tool in controlling heterologous gene expression in cells
03/22/2005US6869975 Linked biaryl compounds
03/22/2005US6869973 Nitrosated and nitrosylated taxanes, compositions and methods of use
03/22/2005US6869968 Such as 3-(4-fluorophenyl)-4-(4-methysulphonylphenyl)-2-(3H)-oxazolone; for treating colorectal cancer, fevers, and inflammation
03/22/2005US6869962 Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use
03/22/2005US6869958 Fused tetrahydropyridine derivatives as matrix metalloproteinase inhibitors
03/22/2005US6869954 Water-soluble phenylpyridazine compounds and compositions containing the same
03/22/2005US6869952 Such as 4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methyl-pyrrolo(2,1-f)(1,2,4)triazin-6-ol; for treament of cancer
03/22/2005US6869945 Antihistamines; respiratory system disorders; antiinflammatory agents
03/22/2005US6869615 Enterically coated to prevent gastrointestinal side effects
03/22/2005US6869610 Pain treatment by peripheral administration of a neurotoxin
03/22/2005US6869605 Anticarcinogenic agents
03/22/2005CA2330092C Benzimidazole compounds as orl1-receptor agonists
03/22/2005CA2178219C Substituted morpholine derivatives and their use as therapeutic agents
03/17/2005WO2005023782A1 Substituted fused pyrimidine-4(3h)-one compound
03/17/2005WO2005023781A1 Guanidine derivatives
03/17/2005WO2005023777A1 Ppar-activating compound and pharmaceutical composition containing same
03/17/2005WO2005023771A1 Chemokine receptor antagonist and medical use thereof
03/17/2005WO2005023741A2 Pharmaceutical compositions containing (+) cannabidiol and derivatives thereof and some such novel derivatives
03/17/2005WO2005009431B1 Methods for treating inflammation and inflammation-associated diseases with a statin and ether
03/17/2005WO2005005415A8 Indoles useful in the treatment of inflammation
03/17/2005WO2005000820A3 4-cyanopyrazole-3-carboxamide derivatives preparation and application thereof as cb1 cannabinoid antagonists
03/17/2005WO2005000817A3 Diphenylpyridine derivatives, preparation and therapeutic application thereof
03/17/2005WO2004084874A3 Mtp inhibitors for inhibiting inflammation
03/17/2005WO2004075843A3 Glycosolated enkephalin agents
03/17/2005WO2004056868A3 Nf-hev compositions and methods of use
03/17/2005WO2003084305A8 Trihydroxy polyunsaturated eicosanoids
03/17/2005WO2002072571A8 Pyridinyl pyrazoles useful for the treatment of copd
03/17/2005WO2002050028A8 Substituted benzoindoles as spla2 inhibitors
03/17/2005US20050059726 For treating thrombosis and factor xa-related cardiovascular and neurodegenerative diseases; 6-Chloro-N-{(3S)-1-[3-fluoro-2'-(methylsulfonyl)-1,1'-biphenyl-4-yl]-2-oxopyrrolidin-3-yl}naphthalene-2-sulfonamide for example
03/17/2005US20050059715 Treatment of pain, particularly neuropathic pain; with serotonin re-uptake inhibitor (gabapentin), serotonin re-uptake inhibitor (sertraline, fluoxetine), noradrenaline re-uptake inhibitor (reboxetine) or serotonin-noradrenaline re-uptake inhibitor (venlafaxine)
03/17/2005US20050059714 2-Cyclopropyl-4-(5-fluoro-2-methoxyphenyl)-4-methyl-1-(1H-pyrrolo[2,3-c]pyridin-2-yl)pentan-2-ol; treating diseases of inflammatory, allergic, or proliferative condition; type II diabetes, obesity, cardiovascular diseases, hypertension, arteriosclerosis, neurological diseases, adrenal and pituitary tumor
03/17/2005US20050059710 Diphenylamino ketone derivatives as MEK inhibitors
03/17/2005US20050059700 Reacting compunds such as 6-methyl-12-oxa-tricyclo[8.2.1.0]trideca-2,4,6-trien-11-ol with compounds such as 4-(2,6-dichloro-phenyl)-piperidine to produce (+-)-cis-1-methyl-7-[[4-(2,6-dichloro-phenyl)piperidin-1-yl)]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol
03/17/2005US20050059694 Antiinflammatory and antiproliferative skin agents for Topical administration of treating skin psoriasis disease; lotions, gels, cream
03/17/2005US20050059688 administering nontoxic, preferential and potent c-kit ligand inhibitors such as imatinib, to humans for treatment of inflammatory diseases such as rheumatoid arthritis
03/17/2005US20050059686 Pyrrolopyrimidines as phosphodiesterase vII inhibitors
03/17/2005US20050059685 such as R)-1,5-Dimethyl 3-(5-hydroxyhexyl)pyrido[2,3-d]pyrimidine-2,4,7(1H,3H,8H)-trione, used for the treatment or prevention of symptoms or manifestations associated with diseases or disorders affected by cytokine intracellular signaling
03/17/2005US20050059671 Hydroxyiminopiperazine compound for therapy and prophylaxis of Urinary incontinence, Inflammatory-bowel disease, addictive disorder, Parkinson's disease, parkinsonism, anxiety, epilepsy, stroke, a seizure, a pruritic condition, psychosis, a cognitive disorder
03/17/2005US20050059666 CCR5 antagonists useful for treating AIDS
03/17/2005US20050059665 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use
03/17/2005US20050059616 administering flavonoids and optionally vitamin E or excipients for the prophylaxis of bone or cardiovascular disorders, headaches, hypertension, cancers, leukemia, arteriosclerosis, Alzheimer's disease, inflammatory diseases, rheumatic diseases, acne, alopecia or psoriasis
03/17/2005US20050059589 Such as cutaneous, ocular, nasal and bronchial allergic disease; interleukins and tumor necrosis factor receptors; competitive binding
03/17/2005US20050059577 Glycosylphosphatidylinositol containing polypeptides
1 ... 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 ... 1272